-

PRA INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against ProAssurance Corporation and Encourages Investors to Contact the Firm Before August 17

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Alabama on behalf of those who acquired ProAssurance Corporation (“ProAssurance” or the “Company”) (NYSE: PRA) securities during the period from April 26, 2019 through May 7, 2020. Investors have until August 17, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The lawsuit alleges that the Company failed to disclose that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; and (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten.

On January 22, 2020, ProAssurance disclosed a $37 million charge to its loss reserves for the fourth quarter of 2019 due to “deteriorating loss experience, driven by a large national healthcare account.” On this news, the price of ProAssurance shares fell $4.18, or 11.1%, to close at $33.40 on January 23, 2020. On February 20, 2020, ProAssurance revealed that the charge was actually $51.5 million, not $37 million.

On May 8, 2020, ProAssurance announced that the large healthcare client would likely not renew its policy and instead would likely exercise an option for tail coverage that would result in an additional $50 million in losses in the second quarter of 2020. On this news, the price of ProAssurance shares fell $4.38, or 21.5%, to close at $15.95 on May 8, 2020.

If you acquired ProAssurance securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, and whistleblower litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
(212) 371-6600
investigations@kmllp.com
www.kmllp.com

Kirby McInerney LLP

NYSE:PRA

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
(212) 371-6600
investigations@kmllp.com
www.kmllp.com

Social Media Profiles
More News From Kirby McInerney LLP

SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 15, 2025, Scorpion Capital published a report that described Soleno’s only product, Vykat XR, as ov...

AGL ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of agilon Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) securities during the period of February 26, 2025 through August 2, 2025, inclusive (“the Class Period”). If you suffered a loss on your agilon investments, you have until March 2, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS]...

FFIV: Kirby McInerney LLP Advises F5, Inc. Investors of Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased F5, Inc. (“F5” or the “Company”) (NASDAQ:FFIV) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your F5 investments, you have until February 17, 2026 to request lead plaintiff appointment. Follow the link below for...
Back to Newsroom